Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of febuxostat on endothelial dysfunction markers and renal progression in chronic kidney disease
TCTR20210224005Phase 4Completed
- Sponsor
- N/A
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of febuxostat in chronic kidney disease (CKD), sponsored by N/A. Started May 2018; status: completed.
02
Drugs
febuxostat
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on TCTR20210224005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210224005.